Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· RobertLufkinMDAudio: American English

The Alzheimer's Lie: It's Not Amyloid | David Perlmutter MD

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

Neurologist David Perlmutter MD says the beta-amyloid theory of Alzheimer's is wrong — and the real culprit is your brain's own immune cells. Here's the science. In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with renowned neurologist and #1 New York Times bestselling author David Perlmutter MD to unpack his new book Brain Defenders. They explore microglia — the brain's immune cells — and how diet, blood sugar, and metabolic health flip these cells from protective ("M2") to destructive ("M1"), driving Alzheimer's, Parkinson's, and other neurodegenerative disease. Perlmutter explains why anti-amyloid drugs offer "trivial" benefit at serious risk, which biomarkers actually predict your brain's future, and what you can start doing today. CHAPTERS: 00:00 — Introduction 01:38 — Why He Left Mainstream Neurology to Prevent Brain Decline 05:24 — Building the World's Largest Integrative Neurology Practice 06:55 — The Common Pathway From Metabolism to Brain Degeneration 08:25 — Why the Beta-Amyloid Theory of Alzheimer's Is Wrong 09:11 — What Are Microglia? The Brain's Immune Cells (M1 vs M2) 12:13 — From Brain "Glue" to Master Regulators of Your Synapses 16:00 — How Body Inflammation and Cytokines Reach the Brain 18:15 — Leaky Gut, the Microbiome, and Brain Degeneration 19:46 — Ultra-Processed Foods Raise Alzheimer's Risk Up to 270% 25:02 — Synaptic Pruning: The Link Between Autism, ADHD and Alzheimer's 29:36 — Why Diabetics Recover Worse From Head Trauma 31:51 — Anti-Amyloid Drugs: "Trivial" Benefit, Serious Harm 35:37 — The Biomarkers to Track: Fasting Glucose, Insulin, A1C 40:09 — On the Horizon: Mitochondrial Therapies and Microglial Transplants 45:26 — Glyphosate, Air Pollution and 40Hz Light Therapy 47:00 — Brain Defenders Releases August 18 — Final Takeaways KEY TAKEAWAYS: • Alzheimer's is increasingly understood as a "synaptopathy" — a disease of lost synapses driven by the brain's own immune cells (microglia), not simply a buildup of beta-amyloid plaque. • Microglia shift from supportive (M2) to destructive (M1) in response to metabolic signals: high blood sugar, insulin resistance, elevated blood pressure, excess body fat, and inflammation. • A long-term cohort found each daily serving of ultra-processed food raised Alzheimer's risk ~13%, with 10+ servings/day linked to a 2.7-fold (270%) increase — and ultra-processed foods make up ~60% of U.S. adult calories. • A Cochrane review of anti-amyloid antibodies found "trivial" cognitive benefit alongside meaningful harm, including brain swelling and microbleeds (ARIA) in a substantial share of patients. • The most actionable brain biomarkers are cheap and accessible: fasting blood glucose, fasting insulin, hemoglobin A1c, waist circumference, and a continuous glucose monitor — aim for optimal, not just "normal." • Emerging frontiers target the mitochondria inside microglia — metformin, CoQ10, urolithin A, exercise, fasting, ketones, and experimental approaches like 40Hz gamma light therapy. STUDIES & SOURCES MENTIONED: • Weinstein et al., J Prev Alzheimers Dis — ultra-processed food and Alzheimer's risk (1,375 participants, ~12.7 years; 13% per serving, 2.7-fold at 10+ servings/day) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12184002/ • Cochrane Review (2026) — anti-amyloid monoclonal antibodies for Alzheimer's: little-to-no cognitive benefit, increased brain swelling and microbleeds — https://www.cochrane.org/evidence/CD016297_are-medicines-anti-amyloid-monoclonal-antibodies-reduce-build-abnormal-proteins-brain-effective • Iaccarino, Tsai et al. (Tsai Lab, MIT) — 40Hz gamma light flicker recruits microglia and reduces amyloid — https://pubmed.ncbi.nlm.nih.gov/30072722/ ───────────────────────────────── 🔔 Subscribe for more evidence-based health insights 📖 Dr. Lufkin's book "Lies I Taught in Medical School": https://robertlufkinmd.com/lies/ 📰 Substack newsletter: https://robertlufkinmd.substack.com 🌐 Website: https://robertlufkinmd.com #brainhealth #alzheimers #davidperlmutter #robertlufkinmd #healthlongevity

RobertLufkinMD · 49 min · Source published: 2026-08-31

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…